Protein protein interactions (PPI) are therapeutic targets of prime interest but the complexity of their interaction interfaces makes difficult the development of PPIs inhibitors. Peptides display great potential for targeting PPIs but without a defined 3D structure, they usually show no affinity. Constrained peptides with a controlled conformation or scaffolds constitute an effective solution but their design requires a significant comprehension of the protein complex at the epitope scale.This work aims at developing a dynamic combinatorial chemistry (DCC) approach to functionalize peptide scaffolds. This approach allows to generate dynamic libraries thanks to equilibrated reversible reactions between molecular building blocks. These dynam...
The horizon of drug discovery is currently expanding to target and modulate protein-protein interact...
Protein-protein interaction (PPI) is a hot topic in clinical research as protein networking has a ma...
Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a ...
Protein protein interactions (PPI) are therapeutic targets of prime interest but the complexity of t...
L’identification de molécules hautement sélectives et de forte affinité représente l’objectif ultime...
Proteins are molecules involved in biological function. Most of them interact with other protein. Di...
Dans le milieu cellulaire, l’activité d’une protéine est souvent conditionnée par l’interaction prot...
We report a quantitative proteomics data analysis pipeline which, coupled to protein-directed dynami...
Dynamic combinatorial chemistry (DCC) has emerged as a powerful strategy to identify ligands for bio...
Major unsolved diseases such as Cancer, cardiopathies or neurodegenerative disorders are frequently ...
Despite their promising biological activity, peptides have a number of unfavorable properties that h...
Peptides and peptidomimetics are strongly re-emerging as amenable candidates in the development of t...
9 p.-8 fig.-2 tab.Protein-directed dynamic combinatorial chemistry (P-D DCC) is considered a powerfu...
Protein-protein interactions (PPIs) and protein surfaces are considered challenging targets for drug...
Cyclic peptides are a promising class of bioactive molecules potentially capable of modulating 'diff...
The horizon of drug discovery is currently expanding to target and modulate protein-protein interact...
Protein-protein interaction (PPI) is a hot topic in clinical research as protein networking has a ma...
Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a ...
Protein protein interactions (PPI) are therapeutic targets of prime interest but the complexity of t...
L’identification de molécules hautement sélectives et de forte affinité représente l’objectif ultime...
Proteins are molecules involved in biological function. Most of them interact with other protein. Di...
Dans le milieu cellulaire, l’activité d’une protéine est souvent conditionnée par l’interaction prot...
We report a quantitative proteomics data analysis pipeline which, coupled to protein-directed dynami...
Dynamic combinatorial chemistry (DCC) has emerged as a powerful strategy to identify ligands for bio...
Major unsolved diseases such as Cancer, cardiopathies or neurodegenerative disorders are frequently ...
Despite their promising biological activity, peptides have a number of unfavorable properties that h...
Peptides and peptidomimetics are strongly re-emerging as amenable candidates in the development of t...
9 p.-8 fig.-2 tab.Protein-directed dynamic combinatorial chemistry (P-D DCC) is considered a powerfu...
Protein-protein interactions (PPIs) and protein surfaces are considered challenging targets for drug...
Cyclic peptides are a promising class of bioactive molecules potentially capable of modulating 'diff...
The horizon of drug discovery is currently expanding to target and modulate protein-protein interact...
Protein-protein interaction (PPI) is a hot topic in clinical research as protein networking has a ma...
Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a ...